Clexane Forte

البلد: نيوزيلاندا

اللغة: الإنجليزية

المصدر: Medsafe (Medicines Safety Authority)

العنصر النشط:

Enoxaparin sodium 150 mg/mL;  

متاح من:

Pharmacy Retailing (NZ) Ltd t/a Healthcare Logistics

INN (الاسم الدولي):

Enoxaparin sodium 150 mg/mL

جرعة:

150 mg/mL

الشكل الصيدلاني:

Solution for injection

تركيب:

Active: Enoxaparin sodium 150 mg/mL   Excipient: Water for injection

الوحدات في الحزمة:

Syringe, glass, Type 1 glass 0.8mL, 1.0mL, 8, 15 syringes (not marketed),

الفئة:

Prescription

نوع الوصفة الطبية :

Prescription

المصنعة من قبل:

Aventis Pharma Manufacturing Pte Ltd

الخصائص العلاجية:

- Treatment of venous thromboembolic disease. - Prevention of thrombus formation in the extra-corporeal circulation during haemodialysis.

ملخص المنتج:

Package - Contents - Shelf Life: Syringe, glass, Type 1 glass 0.8mL, 1.0mL, 8, 15 syringes -   - 24 months from date of manufacture stored at or below 25°C - Syringe, glass, Type 1 glass 0.8mL syringes with automatic safety lock system - 10 dose units - 24 months from date of manufacture stored at or below 25°C - Syringe, glass, Type 1 glass 1.0mL syringes with automatic safety lock system - 10 dose units - 24 months from date of manufacture stored at or below 25°C - Syringe, glass, Type 1 glass 0.8mL syringes - 10 dose units - 24 months from date of manufacture stored at or below 25°C - Syringe, glass, Type 1 glass 1.0mL syringes - 10 dose units - 24 months from date of manufacture stored at or below 25°C

تاريخ الترخيص:

1999-05-10

نشرة المعلومات

Clexane® and Clexane® Forte
*
1
CLEXANE® AND CLEXANE® FORTE*
CONSUMER MEDICINE INFORMATION (CMI) SUMMARY
The full CMI on the next page has more details. If you are worried
about using this medicine, speak to your doctor or
pharmacist.
1.
WHY AM I USING CLEXANE?
Clexane contains the active ingredient enoxaparin sodium. Clexane is
used to prevent clots from getting bigger or stopping
new clots from forming following hospital procedures or illness.
Clexane is also used to treat DVT and heart problems
including unstable angina and heart attack when taken with aspirin.
Clexane is used to stop blood clots forming in the tubes of
your kidney dialysis machine.
For more information, see Section 1. Why am I using Clexane?
in the full CMI.
2.
WHAT SHOULD I KNOW BEFORE I USE CLEXANE?
Do not use if you have ever had an allergic reaction to Clexane,
heparin or any medicine derived from heparin, or any of the
ingredients listed at the end of the CMI. Do not take Clexane if you
have or have had major bleeding disorders, injury to the
brain, stomach or bowel problems, or bacterial infections of the
heart.
TALK TO YOUR DOCTOR IF YOU HAVE ANY OTHER MEDICAL CONDITIONS, TAKE ANY
OTHER MEDICINES, OR ARE PREGNANT OR PLAN TO BECOME
PREGNANT OR ARE BREASTFEEDING.
For more information, see Section 2. What should I know before I use
Clexane?
in the full CMI.
3.
WHAT IF I AM TAKING OTHER MEDICINES?
Some medicines may interfere with Clexane and affect how it works.
A list of these medicines is in Section 3. What if I am taking other
medicines?
in the full CMI.
4.
HOW DO I USE CLEXANE?
•
Your doctor will decide what dose you will receive.
•
Clexane is usually administered by injection under the skin. It can
also be injected into the tubing of a dialysis machine or
into a vein by a doctor or nurse.
More instructions and how to use Clexane can be found in Section 4.
How do I use Clexane?
in the full CMI.
5.
WHAT SHOULD I KNOW WHILE USING CLEXANE?
THINGS YOU
SHOULD DO
•
Remind any doctor, dentist, or pharmacist you visit that you are u

خصائص المنتج

New Zealand Data Sheet
clexane-clexane-forte-ccdsv14-dsv22-20jun22
Page 1
NEW ZEALAND DATA SHEET
1
CLEXANE
® AND CLEXANE
® FORTE
*
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
CLEXANE

SYRINGES
#
Pre-filled syringes, ready-to-use:
20 mg injection
enoxaparin sodium 20mg (equivalent to 2,000 IU anti-Xa activity) in
0.2 mL
40 mg injection
enoxaparin sodium 40mg (equivalent to 4,000 IU anti-Xa activity) in
0.4 mL
Pre-filled graduated syringes with graduated markings, ready-to-use:
60 mg injection
enoxaparin sodium 60mg (equivalent to 6,000 IU anti-Xa activity) in
0.6 mL
80 mg injection
enoxaparin sodium 80mg (equivalent to 8,000 IU anti-Xa activity) in
0.8 mL
100 mg injection
enoxaparin sodium 100mg (equivalent to 10,000 IU anti-Xa activity) in
1.0
mL
CLEXANE

(with safety lock system)
Pre-filled syringes, ready-to-use:
20 mg injection
enoxaparin sodium 20mg (equivalent to 2,000 IU anti-Xa activity) in
0.2 mL
40 mg injection
enoxaparin sodium 40mg (equivalent to 4,000 IU anti-Xa activity) in
0.4 mL
Pre-filled graduated syringes with graduated markings, ready-to-use:
60 mg injection
enoxaparin sodium 60mg (equivalent to 6,000 IU anti-Xa activity) in
0.6 mL
80 mg injection
enoxaparin sodium 80mg (equivalent to 8,000 IU anti-Xa activity) in
0.8 mL
100 mg injection
enoxaparin sodium 100mg (equivalent to 10,000 IU anti-Xa activity) in
1.0
mL
CLEXANE

FORTE SYRINGES
#
New Zealand Data Sheet
clexane-clexane-forte-ccdsv14-dsv22-20jun22
Page 2
Pre-filled graduated syringes with the double graduated markings,
ready-to-use:
120 mg injection
enoxaparin sodium 120mg (equivalent to 12,000 IU anti-Xa activity) in
0.8
mL
150 mg injection
enoxaparin sodium 150mg (equivalent to 15,000 IU anti-Xa activity) in
1.0
mL
CLEXANE

FORTE SYRINGES (with safety lock system)
Pre-filled graduated syringes with the double graduated markings,
ready-to-use:
120 mg injection
enoxaparin sodium 120mg (equivalent to 12,000 IU anti-Xa activity) in
0.8
mL
150 mg injection
enoxaparin sodium 150mg (equivalent to 15,000 IU anti-Xa activity) in
1.